
EVAX Market Capitalization Overview
Market Cap: $38.12M as of May 4, 2026
$38.12M
$6.59M (20.90%)past month
As of May 4, 2026, EVAX has a market capitalization of $38.12M. Over the past 30 days, its market cap has increased by 14.09%, while in the last 12 months, it has increased by 26.5%.
Market capitalization represents the total value of Evaxion Biotech A/S as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
EVAX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of EVAXhelps investors assess the company's size and compare it with competitors for better investment decisions.
Market capitalization represents the total value of Evaxion Biotech A/S as perceived by the stock market. It is calculated by multiplying the current stock price by the total number of outstanding shares.
EVAX Market Cap Formula = Stock Price * Shares Outstanding
The market cap of EVAXhelps investors assess the company's size and compare it with competitors for better investment decisions.
EVAX Market Cap & Key Trends
See Evaxion Biotech A/S’s latest market capitalization, historical trends, and financial insights with AI-powered fundamental data and custom analysis.
Start investing in EVAX
Order type
Buy in
Order amount
Est. shares
0 shares
EVAX Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| May 1, 2026 | $37.49M | +14.09% |
| Apr 1, 2026 | $32.87M | +64.11% |
| Mar 2, 2026 | $20.03M | +2.26% |
| Feb 2, 2026 | $19.59M | -34.18% |
| Jan 2, 2026 | $29.76M | -13.34% |
EVAX End of Year Market Cap History
| Date | Market Cap | Change |
|---|---|---|
| 2026 | $38.12M | +26.50% |
| 2025 | $30.13M | +408.20% |
| 2024 | $5.93M | -68.91% |
| 2023 | $19.08M | -53.69% |
| 2022 | $41.19M | -59.84% |
| 2021 | $102.57M | — |
FAQs About Evaxion Biotech A/S (EVAX) Market Cap
As of May 4, 2026, the market capitalization of EVAX is $38.12M. Market cap represents the total value of a company’s outstanding shares and is a key indicator of its size in the stock market.
In the last 30 days, Evaxion Biotech A/S’s market capitalization has increased by 20.90%, changing from $31.53M to $38.12M as of May 4, 2026.
In the last 3 months, Evaxion Biotech A/S’s market capitalization has increased by —, changing from – to – as of –.
In the year 2025, Evaxion Biotech A/S’s market capitalization increased from $5.93M in January to $30.13M in December, reflecting a 408.2% change.
In the past five years, EVAX has had a compound annual growth rate (CAGR) of -21.73% in market capitalization. This means its market cap has shrunk at an average rate of -21.73% per year.